Ardelyx Inc. (ARDX) had a good day on the market for Monday April 08 as shares jumped 8.26% to close at $3.54. About 463,133 shares traded hands on 2,030 trades for the day, compared with an average daily volume of n/a shares out of a total float of 62.6 million. After opening the trading day at $3.58, shares of Ardelyx Inc. stayed within a range of $3.64 to $3.35.
With today’s gains, Ardelyx Inc. now has a market cap of $221.6 million. Shares of Ardelyx Inc. have been trading within a range of $5.90 and $1.60 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Ardelyx Inc. is based out of Fremont, CA and has some 86 employees. Its CEO is Michael G. Raab.